GENERIC PHARMACEUTICALS Sample Clauses

GENERIC PHARMACEUTICALS. Customer agrees to fully participate in McKesson's Select Generics Program through its auto-substitution feature and to thereby designate this program as Customer's primary source of generic pharmaceuticals. In consideration for the above commitments, McKesson will extend to Customer McKesson Select Generics contract pricing in accordance with the attached. This contract is based upon McKesson Select Generics Program pricing less [+]%. Prices are subject to change; provided however, the contract discount percentage made available under this Agreement will remain the same. A quarterly rebate shall be paid to Customer in accordance with the following schedule based on such above- specified participation: Quarterly McKesson Select Generics Volume (net of Quarterly Rebate % on Net returns, allowances and rebates)McKesson Select Generics Purchases ------------------------------------------------------------------ [+] Customer shall be rebated at [+]% for the [+] ([+]) months of this Agreement and thereafter rebated at the earned rate based on actual quarterly purchases. The rebate check will be due to Customer no later than the 30th of the month following the end of the quarter. A [+]% penalty will be paid to Customer on rebate payments received after the applicable due date as defined above.
Sample 1Sample 2
AutoNDA by SimpleDocs
GENERIC PHARMACEUTICALS. Horizon agrees that upon commencement of the term of this Agreement to participate in McKesson's Select Generics Program through its auto-substitution feature and to thereby designate this program as Horizon's primary source of generic pharmaceuticals. A quarterly rebate shall be paid to Horizon in accordance with the following matrix based on such participation: REBATE UNDER [REDACTED - CONFIDENTIAL REBATE UNDER [REDACTED - CONFIDENTIAL TREATMENT] PAYMENT TERMS TREATMENT] PAYMENT TERMS [redacted - Confidential Treatment] [redacted - Confidential Treatment]00% [redacted - Confidential Treatment]00% [redacted - Confidential Treatment] [redacted - Confidential Treatment]00% [redacted - Confidential Treatment]00% [redacted - Confidential Treatment] [redacted - Confidential Treatment]00% [redacted - Confidential Treatment]00% [redacted - Confidential Treatment] [redacted - Confidential Treatment]00% [redacted - Confidential Treatment]00% [redacted - Confidential Treatment] [redacted - Confidential Treatment]00% [redacted - Confidential Treatment]00%
Sample 1
GENERIC PHARMACEUTICALS. Customer agrees to fully participate in McKesson's OneStop Generics Program through its auto-substitution feature and to thereby designate this program as Customer's primary source of generic pharmaceuticals. A quarterly rebate shall be paid to Customer in accordance with the following schedule based on such participation: Quarterly McKesson OneStop Generics Purchases as a Percentage of Total Rx Purchases (All Purchases net of returns, allowances, rebates Quarterly Rebate % on Net and all credits and adjustments issued McKesson OneStop Generics Purchases and exclusive of drop shipped purchases) (Rebate amounts are not cumulative) *Notwithstanding anything in the foregoing, in order to qualify for the highest rebate percentage on the above-specified McKesson OneStop Generics rebate schedule (XX%), Customer must attain the specified minimum McKesson OneStop Generics to Rx Product purchases ratio of XX% and must also purchase annualized McKesson OneStop Generics volume of $XX. If Customer fails to meet the above-specified $XX purchase volume threshold, the XX rebate percentage tier shall not apply. For example, if the McKesson OneStop Generics to Rx Product purchases ratio is XX% but the annualized quarterly volume is $XX, Customer would qualify for a XX% rebate.
Sample 1
GENERIC PHARMACEUTICALS. McKesson shall pay to Phar-Mor an annual guaranteed rebate based on Phar-Mor's participation in McKesson's Select Generics Program. In order to qualify as participation hereunder, all generic pharmaceuticals purchased by Phar-Mor pharmacies shall be required to be purchased through McKesson's Select Generics Program. Provided Phar-Mor's participation meets the percentage levels as specified below in any year, the guaranteed rebate schedule shall be as follows: Select Generics Rebate Schedule % of Select Generics to Total Rx Rebate ---------------------------------------------------------------------- (*) (*) (*) (*) (*) (*) (*) (*) (*) (*)
Sample 1
GENERIC PHARMACEUTICALS. Medical Group shall use best efforts to prescribe or authorize the substitution of generic pharmaceuticals when appropriate and shall cooperate with Plan formularies and state and federal requirements regarding the substitution of generic pharmaceuticals. This provision shall not be interpreted to interfere with Medical Group's independent medical judgment.
Sample 1
GENERIC PHARMACEUTICALS. Retailer will pay a purchase price for all generic pharmaceuticals purchased under this Agreement at the price applicable under Prime Supplier’s SynerGx generic pharmaceuticals program. The availability and terms of Prime Supplier’s generic pharmaceuticals program to Retailer may change from time to time based on certain volume thresholds. Subject to certain generic purchasing volumes being met by the Company (including the volume of its participating affiliated retailers), the Company shall pay Retailer a rebate equal to [*] percent ([*]%) of the price for Primary SynerGx generic pharmaceuticals purchased and paid for by Retailer under such program. If the volume thresholds are not met, no rebate shall apply. In addition, no rebate shall be payable if this Agreement has been terminated by the Company prior the end of the rebate period or if the Prime Supplier Agreement has been terminated prior to the end of the rebate period. The rebate, as applicable, shall be paid thirty (30) days after the end of each calendar month. The Company may apply the rebate to any amounts owed [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. by Retailer to the Company. Prime Supplier has agreed that it will provide price protection for any generic product Prime Supplier substitutes with a higher priced generic pharmaceutical product (excluding manual overrides by the Company or by Retailer) as a result of Prime Supplier’s fault in availability.
Sample 1

Related to GENERIC PHARMACEUTICALS

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Products Products available under this Contract are limited to Software, including Software as a Service, products and related products as specified in Appendix C, Pricing Index. Vendor may incorporate changes to their product offering; however, any changes must be within the scope of products awarded based on the posting described in Section 1.B above. Vendor may not add a manufacturer’s product line which was not included in the Vendor’s response to the solicitation described in Section 1.B above.

  • Existing Products 1. Hardware - Title and ownership of Existing Hardware Product shall pass to Authorized User upon Acceptance.

  • Diagnostic Services Procedures ordered by a recognized Provider because of specific symptoms to diagnose a specific condition or disease. Some examples include, but are not limited to:

Time is Money Join Law Insider Premium to draft better contracts faster.